Pharmacist misconduct covers a wide range of actions, from dispensing the wrong medication due to carelessness to billing insurance for drugs never provided. State boards of pharmacy define it broadly: any violation of federal, state, or board rules that apply to a licensed pharmacist can be classified as unprofessional conduct. In 2021, boards of pharmacy across the U.S. submitted 2,115 disciplinary records against individual pharmacists to the National Association of Boards of Pharmacy Clearinghouse, with the most common reason (43.1%) being noncompliance with professional requirements.
Dispensing Errors That Cross Into Misconduct
Not every pharmacy mistake is misconduct. A pharmacist who accidentally counts out 28 pills instead of 30 has made a mechanical error. That error becomes potential misconduct when it reflects a pattern of carelessness, a failure to follow standard safety checks, or a deliberate shortcut. Pharmacy errors fall into two categories: mechanical and judgmental. Mechanical errors involve physically preparing or handing out the wrong thing, such as the incorrect drug, dose, quantity, or strength. Judgmental errors involve failures in professional decision-making, like missing a dangerous drug interaction, skipping a required drug utilization review, or failing to counsel a patient about how to take their medication safely.
The distinction between an honest mistake and actionable misconduct often comes down to whether the pharmacist followed established procedures. If a patient who is allergic to one antibiotic receives a chemically related drug and has a severe reaction, regulators will investigate whether the pharmacist checked the allergy history, whether the computer system flagged the interaction, and whether the pharmacist overrode that flag without justification. A single error can trigger a root cause investigation, and serious outcomes like death or permanent injury are classified as sentinel events that demand formal review.
Pharmacists who commit errors that rise to the level of misconduct can face loss of patient trust, civil lawsuits, criminal charges, and disciplinary action from their state board, up to and including license revocation.
Fraud and Financial Misconduct
Financial misconduct in pharmacy most often involves fraudulent billing. The FBI identifies several specific schemes that pharmacies and pharmacists use to steal from insurance programs and patients:
- Phantom billing: Charging for medications or services the patient never received
- Double billing: Submitting multiple claims for the same prescription or service
- Upcoding: Billing for a more expensive drug or service than what was actually dispensed
- Unbundling: Breaking a single service into multiple claims to inflate reimbursement
Prescription-related fraud is another major category. This includes forging prescriptions, diverting legally prescribed controlled substances for illegal sale, and facilitating “doctor shopping” by filling prescriptions a pharmacist knows are not legitimate. These offenses carry both professional consequences from state boards and criminal penalties under federal law. Prison sentences in health care fraud cases routinely reach six to eight years, and financial penalties can run into the millions of dollars.
Practicing While Impaired
A pharmacist who works under the influence of alcohol, illegal drugs, or misused prescription medications is committing misconduct that puts patients at direct risk. Pharmacists have easy access to controlled substances, which makes impairment a recognized problem in the profession. Most states have established Pharmacist Recovery Networks, programs designed to identify, intervene with, and rehabilitate impaired pharmacists before patient harm occurs.
These recovery programs operate with strict confidentiality protections. In Kentucky, for example, all records, communications, and proceedings related to an impaired pharmacist are privileged and cannot be subpoenaed or introduced as evidence in court. The exception is when the recovery committee must report a pharmacist to the board because the pharmacist is not complying with treatment or poses a danger to patients. A pharmacist who enters a recovery program and follows through with treatment may avoid public disciplinary action. One who refuses, relapses without reporting it, or continues practicing while impaired faces board discipline including suspension or loss of their license.
Sexual Misconduct and Boundary Violations
The pharmacist-patient relationship carries an inherent power imbalance, and regulators take boundary violations seriously. Sexual misconduct in a pharmacy setting does not require physical contact. It includes sexual remarks, unnecessary comments about a patient’s appearance, asking about sexual history when it has nothing to do with the consultation, and sharing personal sexual information with a patient. Physical acts like touching of a sexual nature are classified as sexual abuse regardless of whether the patient appeared to consent.
Any romantic or sexual relationship between a pharmacist and a current patient is considered professional misconduct. This applies even if the relationship is fully consensual and even if the patient initiated it. Pharmacists are also prohibited from providing routine care to people they are already in a sexual relationship with, including spouses. After a pharmacist formally ends a professional relationship with a patient, they must wait at least one year before pursuing any romantic or sexual relationship with that person. Violating these rules leads to discipline by the board and can result in a formal finding of sexual abuse.
Violations of Compounding Standards
Pharmacists who prepare custom medications through compounding must follow strict federal and state standards for both sterile and non-sterile preparations. Failing to comply with these standards is classified as unprofessional conduct. Compounding violations include preparing sterile medications in unclean environments, failing to properly test finished products, using expired ingredients, and not maintaining required documentation. These violations are particularly dangerous because contaminated compounded medications have caused fatal infections and widespread harm in past outbreaks.
Other Common Forms of Misconduct
Several additional behaviors regularly lead to board discipline. Failing to maintain proper records for controlled substances, dispensing medications without a valid prescription, and allowing unlicensed staff to perform tasks that require a pharmacist’s direct supervision all qualify. Pharmacists who fail to complete required continuing education, practice with an expired license, or misrepresent their credentials are also subject to action. Violating patient privacy by sharing protected health information without authorization is both a federal offense and grounds for professional discipline.
How Misconduct Complaints Work
If you believe a pharmacist has committed misconduct, complaints go to the state board of pharmacy where the pharmacist practices. Most boards require complaints in writing before an investigation can begin. You can typically submit a complaint by mail, email, or through a form on the board’s website. After receiving a written complaint, a compliance officer reviews the allegations and determines whether a formal investigation is warranted.
Investigations can result in outcomes ranging from a letter of warning to full license revocation. In between, boards may impose fines, require additional education, place a pharmacist on probation, restrict their practice, or suspend their license temporarily. The severity of the sanction depends on the nature of the misconduct, whether patients were harmed, and whether the pharmacist has prior disciplinary history. Disciplinary records are reported to the NABP Clearinghouse, which makes them visible to licensing boards in other states, so a pharmacist cannot simply move and start over after a serious violation.